{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:21:10Z","timestamp":1790742070794,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20232ACB206042"],"award-info":[{"award-number":["20232ACB206042"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-16-10"],"award-info":[{"award-number":["320.6750.2024-16-10"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260628"],"award-info":[{"award-number":["82260628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360629"],"award-info":[{"award-number":["82360629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.intimp.2025.114912","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T14:36:21Z","timestamp":1748615781000},"page":"114912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Acetylation of FABP3 alleviates radioimmunotherapy-induced cardiomyocyte senescence by modulating long-chain polyunsaturated fatty acid metabolism"],"prefix":"10.1016","volume":"160","author":[{"given":"Yuxi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daya","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10405","key":"10.1016\/j.intimp.2025.114912_bb0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jtho.2022.07.1148","article-title":"Durvalumab after sequential Chemoradiotherapy in stage III, Unresectable NSCLC: the phase 2 PACIFIC-6 trial","volume":"17","author":"Garassino","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114912_bb0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.annonc.2022.06.013","article-title":"Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches","volume":"33","author":"Cortiula","year":"2022","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114912_bb0025","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1097\/JS9.0000000000001479","article-title":"Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, and large-sample informatics study","volume":"110","author":"Guo","year":"2024","journal-title":"International Journal of Surgery (London, England)"},{"issue":"6","key":"10.1016\/j.intimp.2025.114912_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189008","article-title":"Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy","volume":"1878","author":"Luo","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2025.114912_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.2301","article-title":"Pembrolizumab plus concurrent Chemoradiation therapy in patients with Unresectable, locally advanced, stage III non-small cell lung Cancer: the phase 2 KEYNOTE-799 nonrandomized trial","volume":"7","author":"Jabbour","year":"2021","journal-title":"JAMA Oncol."},{"issue":"20","key":"10.1016\/j.intimp.2025.114912_bb0040","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(21)00630-6","volume":"23","author":"Zhou","year":"2022","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114912_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11912-020-00925-8","article-title":"New insights into mechanisms of immune checkpoint inhibitor-induced cardiovascular toxicity","volume":"22","author":"Khunger","year":"2020","journal-title":"Curr. Oncol. Rep."},{"issue":"18","key":"10.1016\/j.intimp.2025.114912_bb0055","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10475","key":"10.1016\/j.intimp.2025.114912_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","article-title":"Radiotherapy toxicities: mechanisms, management, and future directions","volume":"405","author":"Verginadis","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2025.114912_bb0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2326-6066.CIR-21-0839","article-title":"Autoantibodies drive heart damage caused by concomitant radiation and PD-1 blockade","volume":"11","author":"Yan","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114912_bb0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2017.12.002","article-title":"PD-1 modulates radiation-induced cardiac toxicity through cytotoxic T lymphocytes","volume":"13","author":"Du","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114912_bb0075","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41568-024-00715-5","article-title":"Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart","volume":"24","author":"Munir","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001293","article-title":"PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction","volume":"8","author":"Xia","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.intimp.2025.114912_bb0090","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","article-title":"Senescence mechanisms and targets in the heart","volume":"118","author":"Chen","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2025.114912_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4155565","article-title":"Acetylation of Atp5f1c mediates cardiomyocyte senescence via metabolic dysfunction in radiation-induced heart damage","volume":"2022","author":"Zeng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2025.114912_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107751","article-title":"Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence","volume":"221","author":"Abdelgawad","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.14336\/AD.2020.0811","article-title":"Cellular senescence affects cardiac regeneration and repair in ischemic heart disease","volume":"12","author":"Yan","year":"2021","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114912_bb0115","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2025.114912_bb0120","article-title":"Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury","volume":"163","author":"Tian","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"43","key":"10.1016\/j.intimp.2025.114912_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado5887","article-title":"Mitochondrial fatty acid oxidation drives senescence","volume":"10","author":"Yamauchi","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11864-022-01041-4","article-title":"New insights into the understanding of mechanisms of radiation-induced heart disease","volume":"24","author":"Wang","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.intimp.2025.114912_bb0135","doi-asserted-by":"crossref","first-page":"1112222","DOI":"10.3389\/fcvm.2023.1112222","article-title":"Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.intimp.2025.114912_bb0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehab430","article-title":"Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy","volume":"43","author":"Michel","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2025.114912_bb0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-pharmtox-051921-090208","article-title":"Pros and cons of long-chain Omega-3 polyunsaturated fatty acids in cardiovascular health","volume":"63","author":"Djuricic","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0150","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00592-024-02325-x","article-title":"Silencing the FABP3 gene in insulin-secreting cells reduces fatty acid uptake and protects against lipotoxicity","volume":"61","author":"Hyder","year":"2024","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.intimp.2025.114912_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gene.2018.07.035","article-title":"Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers","volume":"676","author":"Amiri","year":"2018","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0160","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41467-020-19501-6","article-title":"FABP3-mediated membrane lipid saturation alters fluidity and induces ER stress in skeletal muscle with aging","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2025.114912_bb0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2025.114912_bb0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2015.09.005","article-title":"Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury","volume":"88","author":"Boylston","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114912_bb0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/CIRCULATIONAHA.123.066542","article-title":"Novel Pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function","volume":"149","author":"Xu","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijrobp.2023.07.033","article-title":"Oncostatin M\/Oncostatin M receptor signal induces radiation-induced heart fibrosis by regulating SMAD4 in fibroblast","volume":"118","author":"Xu","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00262-024-03899-9","article-title":"Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study","volume":"74","author":"Chen","year":"2025","journal-title":"Cancer immunology, immunotherapy\u202f: CII"},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00011-024-01979-1","article-title":"Mediation of macrophage M1 polarization dynamics change by ubiquitin-autophagy-pathway regulated NLRP3 inflammasomes in PD-1 inhibitor-related myocardial inflammatory injury","volume":"74","author":"Chen","year":"2025","journal-title":"Inflammation Research\u202f: Official Journal of the European Histamine Research Society [et al]"},{"issue":"6","key":"10.1016\/j.intimp.2025.114912_bb0195","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12482","article-title":"Radiation-induced dysfunction of energy metabolism in the heart results in the fibrosis of cardiac tissues","volume":"24","author":"Xu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0200","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","article-title":"A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues","volume":"13","author":"Saul","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2025.114912_bb0205","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.gendis.2022.03.009","article-title":"Protein post-translational modification by lysine succinylation: biochemistry, biological implications, and therapeutic opportunities","volume":"10","author":"Zhao","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.intimp.2025.114912_bb0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jare.2024.05.003","article-title":"Arachidonic acid in aging: new roles for old players","volume":"70","author":"Qian","year":"2025","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.114912_bb0215","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/hep.32209","article-title":"Shear stress-induced cellular senescence blunts liver regeneration through notch-sirtuin 1-P21\/P16 axis","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0220","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","article-title":"The senescence-associated secretory phenotype and its physiological and pathological implications","volume":"25","author":"Wang","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114912_bb0225","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.intimp.2025.114912_bb0230","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","article-title":"Guidelines for minimal information on cellular senescence experimentation in vivo","volume":"187","author":"Ogrodnik","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2025.114912_bb0235","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1002\/ptr.7965","article-title":"Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases","volume":"37","author":"Liu","year":"2023","journal-title":"Phytotherapy Research\u202f: PTR"},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0240","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1002\/jcb.24243","article-title":"Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells","volume":"113","author":"Song","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.114912_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102547","article-title":"Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons","volume":"59","author":"Guo","year":"2023","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114912_bb0250","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmet.2024.03.006","article-title":"An integrated multi-omics analysis reveals osteokines involved in global regulation","volume":"36","author":"Liang","year":"2024","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0255","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114912_bb0260","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s43587-024-00694-0","article-title":"Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence","volume":"4","author":"Hou","year":"2024","journal-title":"Nature Aging"},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0265","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/s41467-024-45823-w","article-title":"Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence","volume":"15","author":"Sun","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2025.114912_bb0270","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging","volume":"29","author":"Chung","year":"2018","journal-title":"Journal of the American Society of Nephrology\u202f: JASN"},{"issue":"12","key":"10.1016\/j.intimp.2025.114912_bb0275","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1007\/s11427-024-2602-7","article-title":"Inhibition of the RXRA-PPAR\u03b1-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.intimp.2025.114912_bb0280","doi-asserted-by":"crossref","first-page":"1198607","DOI":"10.1155\/2022\/1198607","article-title":"Disturbance of fatty acid metabolism promoted vascular endothelial cell senescence via acetyl-CoA-induced protein acetylation modification","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.intimp.2025.114912_bb0285","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000646","article-title":"Peroxisome proliferator-activated receptor delta and liver diseases","volume":"9","author":"Yamazaki","year":"2025","journal-title":"Hepatology Communications"},{"issue":"1","key":"10.1016\/j.intimp.2025.114912_bb0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925009026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925009026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T07:21:11Z","timestamp":1750490471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925009026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":58,"alternative-id":["S1567576925009026"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114912","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylation of FABP3 alleviates radioimmunotherapy-induced cardiomyocyte senescence by modulating long-chain polyunsaturated fatty acid metabolism","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114912"}}